Milbenin 12,5 mg/125 mg is an antiparasitic for dogs, suitable for the treatment of mixed infections with adult cestodes and nematodes sensitive to praziquantel and milbemycin oxime. It can also be used for prevention of heartworm disease if concurrent treatment against cestodes is required. Milbenin 12,5 mg/125 mg is among the veterinary drugs available without veterinary prescription (VRIJ).
Milbenin 12,5 mg/125 mg has the registration number NL 129070.
Treatment of mixed infections with adult cestodes and nematodes of the following species sensitive to praziquantel and milbemycin oxime:
The veterinary drug may also be used for prevention of heartworm disease (Dirofilaria immitis) if concomitant treatment against cestodes is required.
For oral use.
Recommended minimum dose: 0,5 mg milbemycin oxime and 5 mg praziquantel per kg body weight are administered once.
Administer the veterinary medicine with or after some food.
Depending on the dog's body weight, the practical dosage is as follows:
To ensure correct dosing, body weight should be determined as accurately as possible to avoid underdosing.
When the veterinary medicine is used for the prevention of heartworm disease and at the same time requires treatment against tapeworms, the veterinary medicine may replace the monovalent veterinary medicine for the prevention of heartworm disease.
For the treatment of Angiostrongylus vasorum infections, milbemycin oxime should be administered four times at one-week intervals. It is recommended that, if concomitant treatment against cestodes is indicated, treatment with the veterinary medicinal product should be continued with the monovalent veterinary medicinal product containing only milbemycin oxime for the remaining three weekly treatments.
Administration of the veterinary medicine every four weeks in endemic areas prevents angiostrongyosis by reducing immature adult (L5) and adult parasites, where concomitant treatment against cestodes is indicated.
For treatment against Thelazia callipaeda, milbemycin oxime should be administered as 2 treatments seven days apart. If concomitant treatment against cestodes is indicated, the veterinary medicinal product may replace the monovalent veterinary medicinal product containing milbemycin oxime alone.
Per chewable tablet:
Active ingredients:
Milbemycin oxime 12,5 mg
Praziquantel 125,0 mg
White to off-white, round chewable tablets with evenly distributed brown pigmentation.
Very rarely (<1 animal / 10,000 animals treated, including isolated reports):
